Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - indications as at 15 august 1996: cardiac arrhythmias. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - lidocaine hydrochloride 100 mg/5 ml - solution for injection - 20 mg/ml - lidocaine hydrochloride 20 mg/ml - lidocaine

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - indications as at 15 august 1996: cardiac arrhythmias. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide - indications as at 15 august 1996: cardiac arrhythmias. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - mivacurium chloride 2.14 mg/ml equivalent to 2 mg/ml mivacurium cation - solution for injection - 2 mg/ml - active: mivacurium chloride 2.14 mg/ml equivalent to 2 mg/ml mivacurium cation excipient: hydrochloric acid water for injection - mivacron is a highly selective, short-acting, non-depolarising neuromuscular blocking agent with a fast recovery profile. mivacron is used as an adjunct to general anaesthesia to relax skeletal muscles and to facilitate tracheal intubation and mechanical ventilation.

Australia - English - Department of Health (Therapeutic Goods Administration)

lignocaine hydrochloride anhydrous; lignocaine hydrochloride -

Canada - English - Health Canada

laboratoire aguettant - lidocaine hydrochloride - solution - 20mg - lidocaine hydrochloride 20mg - local anesthetics

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - lidocaine hydrochloride monohydrate 2.13% equivalent to 2% lignocaine hydrochloride anhydrous;   - solution for injection - 2 % - active: lidocaine hydrochloride monohydrate 2.13% equivalent to 2% lignocaine hydrochloride anhydrous   excipient: sodium chloride sodium hydroxide water for injection

Egypt - English - EDA (Egyptian Drug Authority)

astra zeneca-egypt - injection - 20 %